Eczacıbaşı-Monrol Nuclear Products, founded in 1985, was acquired by Bozluolçay family (Bozlu Holding) and has continued its activities in partnership with Eczacıbaşı İlaç Sanayi since 2008 while leading the development of Nuclear Medicine in Turkey since its establishment. Eczacıbaşı-Monrol maintains its expertise around the world with its high-quality radiopharmaceuticals manufactured at EU-GMP quality and logistics infrastructure. Eczacıbaşı-Monrol has 14 world-class manufacturing facilities, six in Turkey and eight abroad (Romania, Bulgaria, Egypt, Dubai, Iraq, Kuwait, Pakistan, and Libya), which are equipped with state-of-the-art, environmentally friendly technology.
Our Mission: We add value to human life with pioneering and innovative approaches in the diagnosis and treatment of vital diseases.
Our Vision: To be the leading company that creates value for all its stakeholders with its innovative and customer-oriented approaches in the diagnosis and treatment of vital diseases in Turkey and neighboring developing countries.